Côte d’Ivoire makes history as first nation to deploy R21/Matrix-M™ Malaria Vaccine

Published on July 15, 2024
  • Today marks the official rollout of the new R21/Matrix-M™ malaria vaccine - co-developed by the University of Oxford and Serum Institute of India, leveraging Novavax’s Matrix-M™ adjuvant technology
  • In a historic step in the battle to beat malaria, the first official vaccination is due to take place in Abidjan, Côte d’Ivoire, this morning and will be subsequently rolled-out in 38 districts across the country. 
  • 15 African countries are expected to introduce malaria vaccines with Gavi support in 2024, and countries plan to reach around 6.6 million children with the malaria vaccine in 2024 and 2025. The new vaccine has been authorised by Ghana, Nigeria, Burkina Faso and the Central African Republic, and many others are preparing to receive shipments
  • R21/Matrix-M™ is a low-dose, highly effective and affordable vaccine which can be manufactured at speed and scale. With the Serum Institute of India committed to producing 100 million vaccines.
Continue reading on website
Other news

COVID-19 phone apps shown to provide real-time information on the spread of infectious diseases

July 11, 2024
Researchers analysing data from mobile phone apps used during the COVID-19 pandemic found that digital contact tracing provides rich insights into epidemic dynamics with unprecedented resolution and speed, revealing how transmission varied by day of the week, gatherings during the 2021 Christmas period, and the UEFA Euro football tournament in July 2021.

Oxford University partners with Oxford City F.C.

July 16, 2024
University of Oxford and Oxford City football club have embarked on a long-term partnership which will see the University and the oldest football club in Oxford working closely together across three key areas: education, research and facilities.